Checchi Capital Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.24M | Sell |
9,839
-692
| -7% | -$91.2K | 0.06% | 183 |
|
|
2026
Q1 | $1.47M | Buy |
10,531
+1,204
| +13% | +$169K | 0.07% | 169 |
|
|
2025
Q4 | $1.14M | Sell |
9,327
-1
| -0% | -$122 | 0.06% | 184 |
|
|
2025
Q3 | $1.04M | Sell |
9,328
-895
| -9% | -$102K | 0.05% | 196 |
|
|
2025
Q2 | $1.13M | Sell |
10,223
-886
| -8% | -$94.3K | 0.06% | 199 |
|
|
2025
Q1 | $1.24M | Buy |
11,109
+544
| +5% | +$56.1K | 0.07% | 181 |
|
|
2024
Q4 | $976K | Buy |
10,565
+297
| +3% | +$26.7K | 0.06% | 203 |
|
|
2024
Q3 | $861K | Buy |
10,268
+87
| +0.9% | +$6.64K | 0.05% | 221 |
|
|
2024
Q2 | $699K | Sell |
10,181
-1,358
| -12% | -$90.6K | 0.04% | 254 |
|
|
2024
Q1 | $845K | Buy |
11,539
+193
| +2% | +$14.8K | 0.07% | 220 |
|
|
2023
Q4 | $919K | Buy |
11,346
+175
| +2% | +$13.6K | 0.07% | 196 |
|
|
2023
Q3 | $837K | Sell |
11,171
-445
| -4% | -$34.2K | 0.08% | 194 |
|
|
2023
Q2 | $895K | Buy |
11,616
+836
| +8% | +$66.7K | 0.08% | 188 |
|
|
2023
Q1 | $894K | Buy |
10,780
+587
| +6% | +$48.6K | 0.09% | 182 |
|
|
2022
Q4 | $875K | Sell |
10,193
-614
| -6% | -$48.6K | 0.09% | 175 |
|
|
2022
Q3 | $667K | Buy |
10,807
+114
| +1% | +$7.19K | 0.06% | 212 |
|
|
2022
Q2 | $639K | Buy |
10,693
+2,435
| +29% | +$151K | 0.06% | 244 |
|
|
2022
Q1 | $491K | Buy |
8,258
+705
| +9% | +$45.1K | 0.04% | 264 |
|
|
2021
Q4 | $548K | Sell |
7,553
-140
| -2% | -$9.64K | 0.05% | 240 |
|
|
2021
Q3 | $537K | Sell |
7,693
-554
| -7% | -$38.9K | 0.05% | 231 |
|
|
2021
Q2 | $568K | Buy |
8,247
+626
| +8% | +$41.8K | 0.06% | 232 |
|
|
2021
Q1 | $493K | Buy |
7,621
+984
| +15% | +$63.5K | 0.05% | 249 |
|
|
2020
Q4 | $387K | Sell |
6,637
-2,593
| -28% | -$156K | 0.04% | 281 |
|
|
2020
Q3 | $583K | Sell |
9,230
-3,107
| -25% | -$215K | 0.06% | 187 |
|
|
2020
Q2 | $949K | Buy |
12,337
+305
| +3% | +$23.4K | 0.11% | 126 |
|
|
2020
Q1 | $900K | Buy |
12,032
+1,805
| +18% | +$125K | 0.09% | 105 |
|
|
2019
Q4 | $665K | Sell |
10,227
-46
| -0.4% | -$3K | 0.09% | 158 |
|
|
2019
Q3 | $651K | Sell |
10,273
-777
| -7% | -$50.8K | 0.08% | 154 |
|
|
2019
Q2 | $747K | Sell |
11,050
-133
| -1% | -$8.75K | 0.09% | 137 |
|
|
2019
Q1 | $727K | Sell |
11,183
-475
| -4% | -$31.6K | 0.09% | 134 |
|
|
2018
Q4 | $729K | Sell |
11,658
-786
| -6% | -$54.9K | 0.09% | 125 |
|
|
2018
Q3 | $961K | Buy |
12,444
+74
| +0.6% | +$5.59K | 0.11% | 123 |
|
|
2018
Q2 | $876K | Buy |
12,370
+241
| +2% | +$17K | 0.11% | 121 |
|
|
2018
Q1 | $914K | Buy |
12,129
+264
| +2% | +$21K | 0.12% | 107 |
|
|
2017
Q4 | $850K | Buy |
11,865
+1,540
| +15% | +$117K | 0.11% | 113 |
|
|
2017
Q3 | $837K | Buy |
10,325
+16
| +0.2% | +$1.22K | 0.08% | 106 |
|
|
2017
Q2 | $730K | Sell |
10,309
-1,498
| -13% | -$99.7K | 0.08% | 120 |
|
|
2017
Q1 | $802K | Buy |
11,807
+480
| +4% | +$33.8K | 0.09% | 114 |
|
|
2016
Q4 | $811K | Sell |
11,327
-1,571
| -12% | -$117K | 0.11% | 110 |
|
|
2016
Q3 | $1.02M | Sell |
12,898
-1,080
| -8% | -$87.7K | 0.12% | 84 |
|
|
2016
Q2 | $1.17M | Buy |
13,978
+102
| +0.7% | +$9.05K | 0.13% | 75 |
|
|
2016
Q1 | $1.27M | Sell |
13,876
-1,076
| -7% | -$97K | 0.28% | 70 |
|
|
2015
Q4 | $1.51M | Buy |
14,952
+1,318
| +10% | +$137K | 0.38% | 49 |
|
|
2015
Q3 | $1.34M | Buy |
13,634
+432
| +3% | +$48K | 0.36% | 58 |
|
|
2015
Q2 | $1.55M | Sell |
13,202
-884
| -6% | -$96.6K | 0.41% | 55 |
|
|
2015
Q1 | $1.38M | Buy |
14,086
+1,604
| +13% | +$163K | 0.41% | 56 |
|
|
2014
Q4 | $1.18M | Buy |
12,482
+852
| +7% | +$88.1K | 0.44% | 55 |
|
|
2014
Q3 | $1.24M | Buy |
11,630
+3,409
| +41% | +$334K | 0.51% | 47 |
|
|
2014
Q2 | $682K | Buy |
8,221
+1,533
| +23% | +$119K | 0.31% | 69 |
|
|
2014
Q1 | $474K | Buy |
6,688
+1,069
| +19% | +$83.8K | 0.29% | 74 |
|
|
2013
Q4 | $422K | Buy |
+5,619
| New | +$391K | 0.33% | 64 |
|
Other funds holding GILD
Checchi Capital Advisers's GILD Position: Q2 2026 in Review
Checchi Capital Advisers reduced its Gilead Sciences (GILD) stake by 6.6% in Q2 2026, selling an estimated $91.2K and leaving 9,839 shares worth $1.24M. The position accounts for 0.06% of the portfolio, ranked #183.
Checchi Capital Advisers first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.55M in Q2 2015. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Checchi Capital Advisers held 9,839 shares of Gilead Sciences worth $1.24M as of Q2 2026.
- Checchi Capital Advisers sold 692 Gilead Sciences shares in Q2 2026, an estimated $91.2K.
- Gilead Sciences made up 0.06% of Checchi Capital Advisers's portfolio in Q2 2026, its #183 holding.
- Checchi Capital Advisers first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
- Checchi Capital Advisers's Gilead Sciences position peaked at $1.55M in Q2 2015.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.